Bibliographie - 2803 - Stabilis 4.0

Last update :
19/11/2024

References 2803

Type :

Journal

Research teams :

Marlborough - Sepracor Inc

Authors :

Bonasia PJ, McVicar WK, Williams B, Ong S.

Title :

Chemical and physical compatibility of levalbuterol inhalation solution concentrate mixed with budesonide, ipratropium bromide, cromolyn sodium or acetylcysteine sodium.

Reference :

Respiratory Care ; 683, 12: 1716-1722. 2008

Level of Evidence :

Physical stability :

Chemical stability :

Other methods :

Comments :

List of drugs

Budesonide

Cromoglycate sodium

Ipratropium bromide

Levalbuterol

N-acetylcysteine

None

21-25°C

N-acetylcysteine	®=? Acetylcysteine sodium Bristol Myers Squibb® 182 mg/l
Levalbuterol	®=? Levalbuterol Sepracor® 0.22 mg/

0.5

None

21-25°C

Levalbuterol	®=? Levalbuterol Sepracor® 0.41 mg/ml
Ipratropium bromide	®=? Ipratropium bromide Dey® 0.16 mg/ml

0.5

None

21-25°C

Budesonide	®=? Budesonide Astra Zeneca 0.2 mg/mL
Levalbuterol	®=? Levalbuterol Sepracor® 0.5 mg/mL

0.5

None

21-25°C

Levalbuterol	®=? Levalbuterol Sepracor® 0.5 mg/ml
Cromoglycate sodium	®=? Cromolyn sodium Alpharma® 8 mg/ml

0.5

Mentions Légales